DCLK1 (doublecortin-like kinase 1), a CSC marker for intestinal and adenoma cancer, has been recently identified as an epigenetic biomarker of colorectal cancer which is regulated by promoter methylation (Vedeld et al., 2014). This evidence concerns the gene DCLK1 and colorectal cancer.